David Sidransky

David Sidransky

Fortune : 5 M $ au 31/05/2026

66 ans
Health Technology
Health Services
Consumer Services

Profil

David Sidransky founded Israel Biotech Fund in 2014, where he is working as General partner from 2014 and Champions Oncology, Inc. in 1985, where he is working as Independent Director from 2025.
Dr. Sidransky also currently works at Biosight Therapeutics, Inc., as Chairman from 2013, Advaxis Immunotherapies, as Chairman, Ayala Pharmaceuticals, Inc., as Chairman from 2017, and various other companies.
Dr. Sidransky also formerly worked at Tamir Biotechnology, Inc., as Chairman from 2007 to 2020, ImClone LLC, as Vice Chairman from 2004 to 2008, Old Ayala, Inc., as Chairman from 2017 to 2023, and various other companies.
Dr. Sidransky received his undergraduate degree in 1981 from Brandeis University and doctorate degree from Baylor College of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/11/2025 767 043 ( 5,52% ) 4 M $ 31/05/2026
20/04/2026 18 491 ( 0% ) 92 580 $ 31/05/2026
25/03/2026 11 083 ( 0,17% ) 8 357 $ 31/05/2026

Postes actifs de David Sidransky

SociétésPosteDébut
CHAMPIONS ONCOLOGY, INC. Fondateur 04/06/1985
GALMED PHARMACEUTICALS LTD. Directeur/Membre du Conseil 01/06/2014
IMMUNE PHARMACEUTICALS, INC. Directeur/Membre du Conseil 26/08/2013
ROSETTA GENOMICS LTD. Directeur/Membre du Conseil 22/12/2009
ASCENTAGE PHARMA GROUP INTERNATIONAL Directeur/Membre du Conseil 31/03/2021
AYALA PHARMACEUTICALS, INC. Président 01/11/2017
Corporate Officer/Principal 01/01/1994
Corporate Officer/Principal 01/07/1998
Directeur/Membre du Conseil -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░

Anciens postes connus de David Sidransky

SociétésPosteFin
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░ ░░░░░ ░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Sidransky

Formation de David Sidransky

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

35

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées35

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Services

Health Technology

Clinical Cancer Research

Commercial Services

Health Services

Health Services

Government

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

The American Association of Cancer Research

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. David Sidransky